ChatGPT Is Sending Visitors to a Research-Peptide Seller: What the Seller Says, and What It Doesn't Tell You

Source note: the claim in this article comes from the operator of qscpeptidology.com, a research-peptide seller we covered in an earlier piece on that industry. The operator shared an analytics report with us on a confidential basis, so we are not publishing the figures and are describing only the general pattern. We have no access to the underlying analytics account and cannot independently verify the report, and the operator has a commercial interest in how it is read. A report supplied by a seller is a claim, not a measurement we have audited.

According to the report, ChatGPT — which Google Analytics classifies as an 'ai-assistant' channel — is among the largest sources of visitors to the site, alongside direct traffic. It is not clearly the single largest source, and a description alone doesn't tell us how large the underlying volumes are.

Traffic reports supplied by a site's own operator commonly include internal visits, ad-tracking tests, and paid traffic, all of which inflate raw numbers. Nothing we were shown lets us audit that.

One plausible explanation for a large direct share, offered by the operator's side, is that some visitors first encountered the site through ChatGPT and later returned via a bookmark or by typing the address, which Google Analytics records as direct. That is a hypothesis, not a finding: direct traffic also includes manually typed addresses, links from apps that don't pass a referrer, and internal visits, and the data can't separate them.

A peer-reviewed study of AI-generated search results for online pharmacy queries examined 262 recommended websites and found that a notable share led to illegal online pharmacies. That study tested earlier search-integrated systems and did not test ChatGPT, but it documented the underlying risk. A chatbot mention is not a license check, a prescription requirement, a purity test, or a regulatory approval — and research-peptide sellers typically label products 'for research use only' and 'not for human consumption.' Industry trackers report that AI-assistant referrals remain a small share of overall web traffic but are growing quickly, with ChatGPT the largest single source.

We haven't logged which prompts produce these referrals, so we can't say what ChatGPT told any user or in what context. How ChatGPT selects which pages to surface when it searches the web isn't public.

Treat an AI answer as a starting point, not a source: ask for citations and open them. For anything you plan to inject, the FDA's BeSafeRx guidance describes what a legitimate online pharmacy looks like — it requires a prescription, is licensed with a state board of pharmacy, lists a U.S. address and phone number, and has a pharmacist available. This site does not recommend sourcing GLP-1 or related peptide drugs from research-labeled sellers, and this article is not a recommendation of any seller, including the one whose claim is discussed here.